Adrian V. S. Hill
Founder chez Oxxon Therapeutics, Inc.
Profil
Adrian V.
S.
Hill is the founder of RioTech Pharmaceuticals Ltd.
founded in 2001.
He is currently a Principal at the University of Oxford.
Mr. Hill's education history includes an undergraduate degree from Magdalen College School Oxford Ltd in 1982.
Mr. Hill is also the founder of Oxxon Therapeutics, Inc.
Postes actifs de Adrian V. S. Hill
Sociétés | Poste | Début |
---|---|---|
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Founder | - |
University of Oxford | Corporate Officer/Principal | - |
Anciens postes connus de Adrian V. S. Hill
Sociétés | Poste | Fin |
---|---|---|
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Founder | - |
Formation de Adrian V. S. Hill
Magdalen College School Oxford Ltd | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Health Technology |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Health Technology |